[go: up one dir, main page]

AU2654692A - Pyrrolobenzoxazine derivatives as 5-ht agonists and antagonists - Google Patents

Pyrrolobenzoxazine derivatives as 5-ht agonists and antagonists

Info

Publication number
AU2654692A
AU2654692A AU26546/92A AU2654692A AU2654692A AU 2654692 A AU2654692 A AU 2654692A AU 26546/92 A AU26546/92 A AU 26546/92A AU 2654692 A AU2654692 A AU 2654692A AU 2654692 A AU2654692 A AU 2654692A
Authority
AU
Australia
Prior art keywords
agonists
antagonists
pyrrolobenzoxazine
derivatives
pyrrolobenzoxazine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26546/92A
Inventor
Masayuki Kato
Shigetaka Nishino
Hisashi Takasugi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of AU2654692A publication Critical patent/AU2654692A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU26546/92A 1991-09-27 1992-09-25 Pyrrolobenzoxazine derivatives as 5-ht agonists and antagonists Abandoned AU2654692A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9120628 1991-09-27
GB919120628A GB9120628D0 (en) 1991-09-27 1991-09-27 Pyrrolobenzoxazine derivatives and process for preparation thereof

Publications (1)

Publication Number Publication Date
AU2654692A true AU2654692A (en) 1993-04-27

Family

ID=10702114

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26546/92A Abandoned AU2654692A (en) 1991-09-27 1992-09-25 Pyrrolobenzoxazine derivatives as 5-ht agonists and antagonists

Country Status (4)

Country Link
JP (1) JPH06510782A (en)
AU (1) AU2654692A (en)
GB (1) GB9120628D0 (en)
WO (1) WO1993006108A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001014348A1 (en) * 1999-08-20 2001-03-01 The Scripps Research Institute Formation of heterocycles
US6784200B2 (en) 2000-10-13 2004-08-31 Bristol-Myers Squibb Pharma Company Bicyclic and tricyclic amines as modulators of chemokine receptor activity
US6586446B1 (en) 1999-10-15 2003-07-01 Bristol-Myers Squibb Company Bicyclic and tricyclic amines as modulators of chemokine receptor activity
CA2384240A1 (en) 1999-10-15 2001-04-26 Dean A. Wacker Benzylcycloalkyl amines as modulators of chemokine receptor activity
WO2001098268A2 (en) 2000-06-21 2001-12-27 Bristol-Myers Squibb Pharma Company Piperidine amides as modulators of chemokine receptor activity
AR036040A1 (en) 2001-06-12 2004-08-04 Upjohn Co MULTICICLIC HETEROARYL COMPOUNDS REPLACED WITH QUINUCLIDINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US6974869B2 (en) 2001-09-18 2005-12-13 Bristol-Myers Squibb Pharma Company Piperizinones as modulators of chemokine receptor activity
CA2466344A1 (en) 2001-11-09 2003-05-22 Pharmacia & Upjohn Company Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands
JP2005523288A (en) 2002-02-19 2005-08-04 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Fused bicyclic-N-bridged-heteroaromatic carboxamides for disease treatment
TW200409630A (en) 2002-09-12 2004-06-16 Bristol Myers Squibb Co N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
ITMI20031468A1 (en) 2003-07-18 2005-01-19 Acraf ATIVE DRUG IN NEUROPATHIC PAIN
ITMI20031467A1 (en) * 2003-07-18 2005-01-19 Acraf ACTIVE DRUG IN NEUROPATHIC PAIN

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035495A (en) * 1975-02-10 1977-07-12 Ayerst Mckenna And Harrison Ltd. Pyrrolobenzoxazines, pyrrolobenzothiazines and process therefor
CA1304082C (en) * 1987-10-22 1992-06-23 Tetsuya Tahara Benzoxazine compounds and pharmaceutical use thereof
DE69026759D1 (en) * 1989-07-03 1996-06-05 Yoshitomi Pharmaceutical Benzazine compounds and their pharmaceutical uses
DK443489D0 (en) * 1989-09-08 1989-09-08 Ferrosan As SUBSTITUTED URINARY COMPOUNDS, THEIR PREPARATION AND USE

Also Published As

Publication number Publication date
GB9120628D0 (en) 1991-11-06
WO1993006108A1 (en) 1993-04-01
JPH06510782A (en) 1994-12-01

Similar Documents

Publication Publication Date Title
AU4422293A (en) Substituted 2-amidotetralins as melatonin agonists and antagonists
SG47877A1 (en) Use of tetrahydrocarbazone derivatives as 5HT receptor agonists
EP0516349A3 (en) 2-hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists
AU2568792A (en) Benzanilide derivatives as 5-ht1d antagonists
AU2280592A (en) New heterocyclic derivatives
AU3952693A (en) Indole derivatives as 5-HT1-like agonists
AU2706292A (en) Heterobiaryl derivatives
EP0707581A1 (en) Indoline derivatives as 5ht 2c? antagonists
HU9600969D0 (en) Indole derivatives as nmda antagonists
SI0736525T1 (en) Benzonitriles as 5-HT agonists and antagonists
AU8429991A (en) Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene d4
AU6435594A (en) Indole derivatives as dopamine d4 antagonists
AU4261293A (en) 1-piperazineacetic derivatives as fibrinogen receptor antagonists
AU1604492A (en) Indole derivatives
AU6215594A (en) Indole derivatives as dopamine d4 antagonists
AU2654692A (en) Pyrrolobenzoxazine derivatives as 5-ht agonists and antagonists
AU8198391A (en) 2-amino-1,4-dihydropyridine derivatives with calcium agonist and alpha1-antagonist activity
AU2759892A (en) N-aryl-n1-azabicyclo-ureas as 5-ht3 antagonists
AU1760992A (en) 2-(pyrrolidinyl-1-methyl)-piperidine derivatives and their use as kappa-recept or agonists
AU1033992A (en) 3-quinuclidine derivatives
AU7186994A (en) Phenyrrole derivatives and their use as dopamine d3 antagonists
AU6994396A (en) Substituted indolylpropyl-piperazine derivatives as 5-ht1dalpha agonists
AU647357B2 (en) Pyrazole derivatives, compositions and use
AU6215794A (en) Indole derivatives as dopamine d4 antagonists
AU8531891A (en) Imidazoline derivatives